|3Jun 27, 6:37 PM ET

MRL Ventures Fund LLC 3

3 · Translate Bio, Inc. · Filed Jun 27, 2018

Insider Transaction Report

Form 3
Period: 2018-06-27
Holdings
  • Series C Preferred Stock

    Common Stock (181,819 underlying)
  • Series B Preferred Stock

    Common Stock (1,666,683 underlying)
Footnotes (2)
  • [F1]The Series B Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F2]The Series C Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION